Pluristem疗法(PSTI)

1.00 0.00 0.0%

今开:0.0昨收:1.0
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:3.2347584E7

Pluristem疗法的最新讨论

usbiostock2018-06-12 22:47

$Pluristem Therapeutics, Inc. (PSTI)$ 公司公布PLX-PAD细胞治疗间歇性跛行临床2期试验结果。试验结果显示,两次注射3亿个PLX-PAD细胞后52周,可显著改善最大步行距离(MWD)。查看全文

usbiostock2018-04-26 00:09

$Pluristem Therapeutics, Inc.(PSTI)$ FDA批准一项有关PLX-PAD细胞疗法的临床3期试验申请,用于治疗髋关节骨折手术修复后的肌肉损伤。查看全文

YanGHuI-2018-01-12 23:20

$Pluristem Therapeutics, Inc.(PSTI)$ Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study查看全文

YanGHuI-2017-12-09 03:12

$Pluristem Therapeutics, Inc.(PSTI)$ HAIFA, Israel, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI), a leading developer of placenta-based cell therapy products, announced today the company will present data from its Phase II-equivalent study of PL...查看全文

YanGHuI-2017-12-07 02:14

$Pluristem Therapeutics, Inc.(PSTI)$ HAIFA, Israel, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI), a leading developer of placenta-based cell therapy products, announced the publication of a peer-reviewed article in Cytotherapy, the official jour...查看全文

YeFIeldTian2011-10-20 07:42

$普拉瑞斯蒂姆治疗(PSTI)$ 把翻译改一下吧。这个是多功能干细胞的意思查看全文

1 2 3

Pluristem疗法的公告

当期报告

$Pluristem疗法(PSTI)$ 8-K Current report, items 5.03, 8.01, and 9.01 Accession Number: 0001213900-22-041096  Act: 34  Size: 3 MB 网页链接

当期报告

$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-039009  Act: 34  Size: 204 KB 网页链接

当期报告

$Pluristem疗法(PSTI)$ 8-K Current report, items 5.02 and 5.07 Accession Number: 0001213900-22-034605  Act: 34  Size: 209 KB 网页链接

季度财报

$Pluristem疗法(PSTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-22-024864  Act: 34  Size: 3 MB 网页链接

股东委托书协议

$Pluristem疗法(PSTI)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-22-021895  Act: 34  Size: 1 MB 网页链接

当期报告

$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-014625  Act: 34  Size: 196 KB 网页链接

当期报告

$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-010987  Act: 34  Size: 197 KB 网页链接

当期报告

$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-009545  Act: 34  Size: 203 KB 网页链接

$Pluristem疗法(PSTI)$ 内部交易: 2022-02-10,Director,Aberman Zami ,买入,80616普通股, $1.80

持股变动声明

$Pluristem疗法(PSTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-007471  Size: 6 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19